Search clinical trials for: TAS-102 oral solution

Total 1863 results

National Taiwan University Hospital
Microbio Co Ltd

Recruiting

MS-20 on Patients With Ulcerative Colitis(UC)

Ulcerative Colitis

Taiwan
IBSA Institut Biochimique SA
Cromsource

Active, not recruiting

Use of Tirosint®-SOL or Tablet Formulations of Levothyroxine in Pediatric Patients With Congenital Hypothyroidism (CH)

Congenital Hypothyroidism

United States
Mead Johnson Nutrition

Completed

Clinical Effectiveness and Safety of a Novel Oral Rehydration Solution

Gastroenteritis Acute

Thailand
QOL Medical, LLC

Recruiting

7-Day Trial of Sucraid for Alleviating CSID Symptoms in Subjects With Low, Moderate, and Normal Sucrase Levels

Congenital Sucrase-Isomaltase Deficiency | CSID | Sucrase Isomaltase Deficiency

United States
G. d'Annunzio University

Completed

PrevenTion of Contrast-inducEd nephroAThy With urinE Alkalinization (TEATE)

Acute Kidney Injury | Contrast Media Reaction

Italy
Lee's Pharmaceutical Limited

Unknown

Evaluating Iron Protein Succinylate Oral Solution in Treating Chronic Heart Failure and Iron Deficiency

Iron-deficiency | Chronic Heart Failure
US Department of Veterans Affairs

Completed

Safety and Efficacy of Routine Colonoscopy Preparations

Spinal Cord Injury

United States
Takeda

Completed

Safety, Tolerability, and Pharmacokinetics of Multiple-Dose TAK-058 in Healthy Participants

Healthy Volunteers

United States
Takeda

Completed

Phase 1, TAK-648, Single-Rising Dose Study

Healthy Volunteers
Presage Biosciences
Takeda

Withdrawn

CIVO Intratumoural Microdosing of Anti-Cancer Therapies in Australia

Solid Tumour

Australia
Bristol-Myers Squibb

Completed

A Study of Milvexian Using an IV Microtracer With Additional Formulation and Food Effect Comparison in Healthy Participants

Healthy Volunteers

United Kingdom
Georgetown University

Terminated

Ph 2 Study of TAS-102 / Bevacizumab Maintenance Therapy Post Induction Chemotherapy in Metastatic Colorectal Cancer (ALEXANDRIA)

Metastatic Colorectal Cancer

United States
Menarini Group

Withdrawn

Preliminary Efficacy and Safety Study of Oral Nepadutant in Infant With Colic Not Responding to Conventional Treatment (nocry-a)

Infantile Colic
Genuine Research Center, Egypt
Bio Med for Pharmaceuticals Industries (BIOMED), Egypt

Completed

Bioequivalence Study of Flibanserin From AphroFemine 100 mg F.C.T (Bio Med for Pharmaceuticals Industries (BIOMED), Egypt) Versus Addyi 100 mg Tablets (Sprout Pharmaceuticals, Inc., USA)

Healthy

Egypt
Takeda

Completed

A Study of TAK-510 in Healthy Adults

Healthy Participants

United States
Calithera Biosciences, Inc

Withdrawn

A Study to Assess Mass Balance, Pharmacokinetics (PK), and Metabolism of Orally Administered [14 C]-TAK-659 in Participants With Advanced Solid Tumor and/or Lymphoma Malignancies

Advanced Solid Neoplasms | Lymphoma Neoplasms
Cassava Sciences, Inc.
National Institute on Aging (NIA)

Completed

PTI-125 for Mild-to-moderate Alzheimer's Disease Patients

Alzheimer Disease

United States
Takeda

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Single- and Multiple-Doses of TAK-020 in Healthy Volunteers

Healthy Volunteers

United States
Takeda

Terminated

Effects of TAK-448 in Middle-aged and Older Men With Low Testosterone

Low Testosterone

United States
ORIC Pharmaceuticals

Terminated

Study of ORIC-101 in Combination With Enzalutamide

Prostatic Neoplasms

United States
Atriva Therapeutics GmbH
SGS Life Sciences, a division of SGS Belgium NV

Completed

Phase 1 Study of ATR-002

Influenza

Belgium
Takeda

Completed

A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of TAK-079 in Healthy Participants

Autoimmune Disease

United Kingdom
HaEmek Medical Center, Israel

Terminated

Impact of Oral Contrast in the Large Intestine on the Recognition of Appendix

Appendicitis

Israel
Fuda Cancer Hospital, Guangzhou
Shengxin Biotechnology Institute, Beijing

Completed

Bioinformation Therapy for Breast Cancer

Advanced Breast Cancer

China
Clinical Nutrition Research Centre, Singapore

Completed

The Dose Effects of Isomaltulose and Sucrose on Glycaemic and Insulinemic Response

Obesity | Type 2 Diabetes | Pre Diabetes

Singapore
BioCryst Pharmaceuticals

Terminated

Study of Forodesine Hydrochloride in Patients With Relapsed/Refractory Precursor T-Lymphoblastic Leukemia/Lymphoma Who Have Failed Two or More Prior Treatment Regimens

Lymphoma | Leukemia

United States
Radboud University Medical Center

Completed

Bioequivalence Study in Healthy Volunteers of a New Paediatric Formulation of Valacyclovir (VALID-I)

Varicella Zoster Virus Infection | Herpes Simplex Virus Infection

Netherlands
Fuda Cancer Hospital, Guangzhou
Shengxin Biotechnology Institute, Beijing

Completed

Bioinformation Therapy for Lung Cancer

Small-cell Lung Cancer

China
Fuda Cancer Hospital, Guangzhou
Shengxin Biotechnology Institute, Beijing

Completed

Bioinformation Therapy for Intestinal Cancer

Advanced Intestinal Cancer

China
Fuda Cancer Hospital, Guangzhou
Shengxin Biotechnology Institute, Beijing

Completed

Bioinformation Therapy for Pancreatic Cancer

Unresectable Pancreatic Cancer

China
Fuda Cancer Hospital, Guangzhou
Shengxin Biotechnology Institute, Beijing

Completed

Bioinformation Therapy for Gastric Cancer

Advanced Gastric Cancer

China
Kyung Hee University Hospital at Gangdong

Completed

Safety and Efficacy of Low-volume Preparation in the Elderly: Oral Sulfate Solution

Bowel Preparation

Korea, Republic of
Takeda
COUR Pharmaceuticals Development Company, Inc.

Completed

Study of the Safety, Pharmacodynamics, Efficacy, and PK of TIMP-GLIA in Subjects With Celiac Disease

Celiac Disease

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI); Taiho Pharmaceutical Co., Ltd.

Completed

TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)

Liver Cancer

United States
Fujian Cancer Hospital

Recruiting

TAS-102 Combined With Bevacizumab and Tislelizumab Third-line or Above in the Treatment of Liver Metastasis in Colorectal Cancer

Colorectal Cancer | Immunotherapy

China
University of Zurich

Completed

Intratendinous Genipin Injection in Horses With Tendon Injuries

Superficial Digital Flexor Tendonitis

Switzerland
Beijing Tiantan Hospital
Beijing Stroke Association

Recruiting

Ginkgo Leaf Extract and Armillariella Mellea Powder Oral Solution for the Treatment of Motoric Cognitive Risk Syndrome

Aging | Mild Cognitive Impairment | Motoric Cognitive Risk Syndrome | Locomotive Syndrome

China
Cassava Sciences, Inc.
National Institute on Aging (NIA)

Completed

Simufilam (PTI-125), 100 mg, for Mild-to-moderate Alzheimer's Disease Patients (PTI-125)

Alzheimer Disease

United States, Canada
SynAct Pharma Aps
NBCD A/S

Completed

A Safety & Efficacy Study of Treatment With AP1189 in Rheumatoid Arthritis Patients naïve to DMARD Treatment (EXPAND)

Rheumatoid Arthritis

Moldova, Republic of
UCB BIOSCIENCES, Inc.
Pharmaceutical Research Associates

Completed

A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications (VALOR)

Epilepsy

United States, Australia, Belgium, Brazil, Bulgaria, China, Czechia, France, Germany, Hungary, Israel, Italy, Japan, Korea, Republic of, Mexico, Poland, Portugal, Romania, Russian Federation, Slovakia, Spain, Taiwan
Menarini Group

Completed

Preliminary Efficacy and Safety Study of Oral Nepadutant in Infant Colic (no-cry)

Infantile Colic

Russian Federation, Germany, Poland, Sweden
Marijn Lijffijt, PhD
Michael E. DeBakey VA Medical Center; VistaGen Therapeutics, Inc.

Completed

Electrophysiological Biomarkers of AV-101

Healthy

United States
Industrial Farmacéutica Cantabria, S.A.
Bioskin GmbH; BioClever 2005 S.L.

Not yet recruiting

Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia

Androgenetic Alopecia | Female Pattern Baldness
National Cancer Center, Korea
Seoul National University Hospital; Seoul National University Bundang Hospital and other collaborators

Unknown

Difference of Surgical Site Infection Between Using Sodium Picosulfate Solution(PicosolutionⓇ) and Oral Sulfate Tablet(ORA·FANGⓇ) in Colorectal Cancer Surgery

Colorectal Cancer

Korea, Republic of
National University Hospital, Singapore

Unknown

Effects of Probiotics in Preventing Oral Mucositis

Head-and-neck Cancer

Singapore
Fuda Cancer Hospital, Guangzhou
Shengxin Biotechnology Institute, Beijing

Completed

Bioinformation Therapy for Liver Cancer

Liver, Cancer of, Non-Resectable

China
Ranbaxy Laboratories Limited

Completed

A Comparitive Bioavailability Study of Metformin Hydrochloride Liquid 500mg/ 5 mL Under Fasting Conditions and After Low and High Fat Meal

Healthy
Jazz Pharmaceuticals

Completed

Safety and Tolerability Study Comparing Sodium Oxybate Given as an Oral Solution to a Single-blinded Combination of Oral Tablets Plus Oral Solution in Subjects With Fibromyalgia

Fibromyalgia

United States
University of California, Los Angeles
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

The Role of Pulsatile Insulin Secretion (A Study Investigating the Effects of Partial Pacreatectomy on Glucose Metabolism) (Pilot OGTT)

Impaired Glucose Tolerance

United States
Second Affiliated Hospital of Wenzhou Medical University

Completed

Efficacy and Safety of Lactulose for Bowel Preparation in Patients With Inflammatory Bowel Disease

IBD

China

Search clinical trials for: TAS-102 oral solution

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cyprus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations